Vanda Pharmaceuticals (VNDA) Earnings Date, Estimates & Call Transcripts $4.25 0.00 (-0.02%) As of 10:34 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Vanda Pharmaceuticals Earnings Summary Upcoming Earnings DateMay. 6After Market ClosesEstimatedConsensus EPS (Feb. 13) -$0.14 Actual EPS (Feb. 13) -$0.08 Beat By $0.06 Actual Revenue (Feb. 13) $53.19MVanda Pharmaceuticals issued Q4 2024 earnings on February 13, 2025, reporting an EPS of -$0.08, which topped the consensus estimate of -$0.14 by $0.06. Quarterly revenue was reported to be $53.19 million, above analysts' expectations of $51 million. With a trailing EPS of -$0.32, Vanda Pharmaceuticals' earnings are expected to grow next year, from ($1.12) to ($0.27) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Annual Report (10-K)VNDA Upcoming EarningsVanda Pharmaceuticals' Q1 2025 earnings is scheduled for Tuesday, May 6, 2025, with a conference call scheduled on Wednesday, May 7, 2025 at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Vanda Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Vanda Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataVNDA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VNDA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Vanda Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.52-$0.52-$0.52Q2 20251-$0.19-$0.19-$0.19Q3 20251-$0.11-$0.11-$0.11Q4 20251-$0.11-$0.11-$0.11FY 20254-$0.93-$0.93-$0.93Q1 20261-$0.08-$0.08-$0.08Q2 20261$0.06$0.06$0.06Q3 20261$0.10$0.10$0.10Q4 20261$0.14$0.14$0.14FY 20264$0.22$0.22$0.22 Vanda Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/6/2025(Estimated)--------2/13/2025Q4 2024-$0.14-$0.08+$0.06-$0.08$51.00M$53.19M7/31/2024Q2 2024--$0.08 -$0.08-$0.08-$50.47M5/8/2024Q1 2024$0.05-$0.07 -$0.12-$0.07$48.50M$47.46M2/7/2024Q4 2023-$0.09-$0.04+$0.05-$0.04$37.00M$45.27M7/27/2023Q2 2023-$0.13$0.03+$0.16$0.03$49.00M$46.06M5/3/2023Q1 2023-$0.06+$0.06$0.06-$62.50M Vanda Pharmaceuticals Earnings - Frequently Asked Questions When is Vanda Pharmaceuticals's earnings date? Vanda Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based off last year's report dates. Learn more on VNDA's earnings history. What guidance has Vanda Pharmaceuticals issued on next quarter's earnings? Vanda Pharmaceuticals issued an update on its FY 2025 earnings guidance on Thursday, February, 13th. The company issued revenue guidance of $210.0 million-$250.0 million, compared to the consensus revenue estimate of $284.9 million. Did Vanda Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Vanda Pharmaceuticals (NASDAQ:VNDA) reported ($0.08) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.14) by $0.06. Learn more on analysts' earnings estimate vs. VNDA's actual earnings. How can I listen to Vanda Pharmaceuticals's earnings conference call? The conference call for Vanda Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Vanda Pharmaceuticals's conference call transcript? The conference call transcript for Vanda Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Vanda Pharmaceuticals generate each year? Vanda Pharmaceuticals (NASDAQ:VNDA) has a recorded annual revenue of $198.77 million. How much profit does Vanda Pharmaceuticals generate each year? Vanda Pharmaceuticals (NASDAQ:VNDA) has a recorded net income of -$18.90 million. VNDA has generated -$0.32 earnings per share over the last four quarters. What is Vanda Pharmaceuticals's EPS forecast for next year? Vanda Pharmaceuticals's earnings are expected to grow from ($1.12) per share to ($0.27) per share in the next year. More Earnings Resources from MarketBeat Related Companies Novavax Earnings OPKO Health Earnings Geron Earnings Myriad Genetics Earnings Verastem Earnings Rigel Pharmaceuticals Earnings XOMA Earnings Emergent BioSolutions Earnings Codexis Earnings Sangamo Therapeutics Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Markets Think Robinhood Earnings Could Send the Stock UpIs the Floor in for Lam Research After Bullish Earnings?Texas Instruments: Earnings Beat, Upbeat Guidance Fuel RecoveryMarket Anticipation Builds: Joby Stock Climbs Ahead of EarningsIs Intuitive Surgical a Buy After Volatile Reaction to Earnings?Seismic Shift at Intel: Massive Layoffs Precede Crucial EarningsRocket Lab Lands New Contract, Builds Momentum Ahead of Earnings This page (NASDAQ:VNDA) was last updated on 4/28/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored‘Wheels Are Falling Off’ the U.S. Stock MarketThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vanda Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vanda Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VNDA Stock Free VNDA Stock Alerts